I. Demographic Information GENDER NUMBER OF CASES PERCENT OF CASES. Male % Female %

Similar documents
Summary Statistics of Reported and Verified Cases of Tuberculosis in San Joaquin County in 2012, (N=44) County Rate = 6.3 Cases per 100,000 Population

2014 Annual Report Tuberculosis in Fresno County. Department of Public Health

ANNUAL TUBERCULOSIS REPORT OREGON Oregon Health Authority Public Health Division TB Program November 2012

2013 Annual Report Tuberculosis in Fresno County. Department of Public Health

2015 Annual Report Tuberculosis in Fresno County. Department of Public Health

Annual Tuberculosis Report Oregon 2007

The Epidemiology of Tuberculosis in Minnesota,

Tuberculosis in Chicago 2007

Scott Lindquist MD MPH Tuberculosis Medical Consultant Washington State DOH and Kitsap County Health Officer

2016 Annual Tuberculosis Report For Fresno County

What you need to know about diagnosing and treating TB: a preventable, fatal disease. Bob Belknap M.D. Denver Public Health November 2014

TB: Management in an era of multiple drug resistance. Bob Belknap M.D. Denver Public Health November 2012

Diagnosis and Treatment of Tuberculosis, 2011

CHAPTER:1 TUBERCULOSIS. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY

Fundamentals of Tuberculosis (TB)

INDEX CASE INFORMATION

Tuberculosis Epidemiology

2008 Tuberculosis Report

Pediatric Tuberculosis Lisa Y. Armitige, MD, PhD September 14, 2017

CHAPTER 3: DEFINITION OF TERMS

Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016

Treatment of Active Tuberculosis

Pediatric TB Theresa Barton, MD

Yakima Health District BULLETIN

What you need to know about diagnosing and treating TB: a preventable, fatal disease. Bob Belknap M.D. Denver Public Health November 2013

Tuberculosis Tools: A Clinical Update

Recognizing MDR-TB in Children. Ma. Cecilia G. Ama, MD 23 rd PIDSP Annual Convention February 2016

Tuberculosis Reporting, Waco-McLennan County Public Health District TB Control WMCPHD (254)

Research in Tuberculosis: Translation into Practice

Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis

TB Nurse Case Management San Antonio, Texas July 18 20, 2012

Diagnosis and Management of TB Disease Lisa Armitige, MD, PhD September 27, 2011

Tuberculosis: A Provider s Guide to

Tuberculosis Surveillance

TB Nurse Case Management San Antonio, Texas March 7 9, Pediatric TB Kim Connelly Smith, MD, MPH March 8, 2012

Pediatric TB Lisa Armitige, MD, PhD September 28, 2011

TB Intensive Houston, Texas. Childhood Tuberculosis Kim Connelly Smith. November 12, 2009

has the following disclosures to make:

TB Intensive San Antonio, Texas August 7-10, 2012

Northwestern Polytechnic University

Report on Tuberculosis in California, 2012

Tuberculosis (TB) Fundamentals for School Nurses

Tuberculosis Intensive

Errors in Dx and Rx of TB

ACTIVE TUBERCULOSIS IN MACOMB COUNTY, A Review of TB Program Data,

TUBERCULOSIS. Presented By: Public Health Madison & Dane County

TB in Foreign Born and High Risk Populations

Diagnosis and Medical Management of Latent TB Infection

Communicable Disease Control Manual Chapter 4: Tuberculosis

Tuberculosis Overview

Tuberculosis 6/7/2018. Objectives. What is Tuberculosis?

11/3/2009 SECOND EDITION Madhukar Pai McGill University. ISTC Training Modules Introduction

TB in Children. Rene De Gama Block 10 Lectures 2012

Rapid Diagnosis and Detection of Drug Resistance in Tuberculosis

Etiological Agent: Pulmonary Tuberculosis. Debra Mercer BSN, RN, RRT. Definition

Managing Complex TB Cases Diana M. Nilsen, MD, RN

Pediatric Drug-Resistant TB in China

Laboratory Diagnosis for MDR TB

TB the basics. (Dr) Margaret (DHA) and John (INZ)

Tuberculosis in Alameda County, 2009

Diagnosis and Medical Management of TB Disease. Quratulian Annie Kizilbash, MD, MPH March 17, 2015

10/3/2017. Updates in Tuberculosis. Global Tuberculosis, WHO 2015 report. Objectives. Disclosures. I have nothing to disclose

The Elimination of Tuberculosis. Richard E. Chaisson, MD. Center for TB Research Center for AIDS Research Johns Hopkins University

PEDIATRIC TUBERCULOSIS. Objectives. Children are not just small adults. Pediatric Tuberculosis 1

TB In Detroit 2011* Early TB: Smudge Sign. Who is at risk for exposure to or infection with TB? Who is at risk for TB after exposure or infection?

PEDIATRIC TUBERCULOSIS

Tuberculosis in Wales Annual Report 2015

Treatment of Tuberculosis, 2017

Tuberculosis Populations at Risk

Diagnosis & Medical Case Management of TB Disease. Lisa Armitige, MD, PhD October 22, 2015

TB BASICS: PRIORITIES AND CLASSIFICATIONS

TB trends and TB genotyping

4/25/2012. The information on patterns of infection and disease can assist in: Assessing current and evolving trends in TB

CDC IMMIGRATION REQUIREMENTS:

MULTIDRUG- RESISTANT TUBERCULOSIS. Dean Tsukayama Hennepin County Medical Center Hennepin County Public Health Clinic

The authors assessed drug susceptibility patterns

Annual surveillance report 2015

Tuberculosis. New TB diagnostics. New drugs.new vaccines. Dr: Hussein M. Jumaah CABM Mosul College of Medicine 23/12/2012

TB: A Supplement to GP CLINICS

Chapter 1 Overview of Tuberculosis Epidemiology in the United States

Substance Abuse and Tuberculosis Oklahoma City, Oklahoma November 17, 2010

Computed Tomography (CT) Scan Features of Pulmonary Drug-Resistant Tuberculosis in Non-HIV-Infected Patients

5. HIV-positive individuals treated with INH should receive Pyridoxine (B6) 25 mg daily or 50 mg twice/thrice weekly on the same schedule as INH

DIAGNOSIS AND MEDICAL MANAGEMENT OF TB DISEASE

Ken Jost, BA, has the following disclosures to make:

Epidemiology and diagnosis of MDR-TB in children H Simon Schaaf

Patient History 1. Patient History 2. Social History. The Role of Surgery in the Management of TB. Reynard McDonald, MD & Paul Bolanowski, MD

Tuberculosis. WRAIR- GEIS 'Operational Clinical Infectious Disease' Course UNCLASSIFIED

At the end of this session, participants will be able to:

TB BASICS: PRIORITIES AND CLASSIFICATIONS

New Tuberculosis Guidelines. Jason Stout, MD, MHS

Tuberculosis Elimination: The Role of the Infection Preventionist

HISTORY TB = 25% ADULT DEATHS EGYPTIAN MUMMIES: SPINAL TB. 17 th -18th CENTURIES- URBANIZATION MID 24

Core Curriculum on Tuberculosis: What the Clinician Should Know

Pediatric Tuberculosis

HISTORY TB = 25% ADULT DEATHS MID 24 PRE-ANTIBIOTIC ERA

Tuberculosis in Wales Annual Report 2016

Tuberculosis Impact in Boston Residents: 2014

TB Intensive Houston, Texas October 15-17, 2013

TB Nurse Case Management San Antonio, Texas April 9-11, 2013

Transcription:

San Joaquin County (SJC) in 03, (N=43) County Rate = 6. Cases per 00,000 Population I. Demographic Information Table I-A: TB cases by gender, SJC, 03 (N=43) GENDER NUMBER OF CASES Male 6 60.5% Female 7 39.5% Table I-B: TB cases by age group at time of diagnosis, SJC, 03 (N=43) AGE GROUP NUMBER OF CASES 0 4 4 9.3% 5 4.3% 5 4 5.6% 5 44 7 6.3% 45 64 6 4.0% 65+ 0 46.5% Table I-C: TB cases by city of residence at time of diagnosis, SJC, 03 (N=43) CITY OF RESIDENCE NUMBER OF CASES RATE PER 00,000 POPULATION Stockton 34 79.%.5 Lodi 3 7.0% 4.8 Tracy 3 7.0% 3.6 Manteca.3%.4 Other San Joaquin County cities 4.7% NA Population denominator source: State of California, Department of Finance, E Population Estimates for Cities, Counties and the State with Annual Percent Change January, 0 and 03, Sacramento, California, May 03 Population denominators not available for some San Joaquin County cities SJCPHS Epidemiology Program

San Joaquin County (SJC) in 03, (N=43) County Rate = 6. Cases per 00,000 Population Table I-D: TB cases by select race/ethnicity, SJC, 03 (N=43) RACE/ETHNICITY NUMBER OF CASES RATE PER 00,000 POPULATION Hispanic 0 3.3% 3.6 Asian/P.I. 8 65.% 8. Cambodian 4 3.6% NA Filipino 8 8.6% NA Hmong 3 7.0% NA Indian.3% NA Korean.3% NA Pakistani.3% NA White 4 9.3%.6 Multi Race.3% 4.5 A.I./A.N. 0 0.0% 0.0 Black 0 0.0% 0.0 Population denominator source: State of California, Department of Finance, P 3 Population Projections by Race/Ethnicity and Detailed Age 00 through 060 (as of July ), Sacramento, California, April 04 03 Population denominators not available for Asian/Pacific Islander subpopulations Table I-E: TB cases by country of origin, SJC, 03 (N=43) COUNTRY OF ORIGIN NUMBER OF CASES U.S. Born 6 37.% Foreign Born 7 6.8% Cambodia 8 8.6% Philippines 8 8.6% Mexico 6 4.0% Laos 4.7% India.3% Korea.3% Thailand.3% SJCPHS Epidemiology Program

San Joaquin County (SJC) in 03, (N=43) County Rate = 6. Cases per 00,000 Population II. Clinical Profile of Reported Cases Table II-A: TB cases by diagnosis category, SJC, 03 (N=43) TB DIAGNOSIS NUMBER OF CASES Previous Diagnosis of Tuberculosis 4.7% Vital Status Deceased at Time of Diagnosis 3 7.0% Site of Disease Pulmonary Only 3 7.% Site of Disease Extrapulmonary Only 6 4.0% Pleural 3 7.0% Cervical 4.7% Lymphatic, other 4.7% Axillary.3% Intrathoracic.3% Other.3% Site of Disease Both Pulmonary and Extrapulmonary 6 4.0% Pulmonary & Lymphatic 4.7% Miliary 4.7% Pulmonary & Axillary.3% Pulmonary & Meningeal.3% Extrapulmonary subcategories are not mutually exclusive Pulmonary & Other.3% SJCPHS Epidemiology Program 3

San Joaquin County (SJC) in 03, (N=43) County Rate = 6. Cases per 00,000 Population Table II-B: TB cases by select clinical factors, SJC, 03 (N=43) CLINICAL FACTOR DENOMINATOR Tuberculin Skin Test Performed 7 6.8% Tuberculin Skin Test Positive PPD /7 8.5% Interferon Gamma Release Assay (IGRA) Test Performed 5 34.9% IGRA Positive 4/5 93.3% Sputum Smear Test Performed 34 79.% Sputum Smear Positive AFB 0/34 9.4% Sputum Culture Test Performed 34 79.% Sputum Culture Positive 4/34 70.6% Other Culture Test Performed 5 58.% Other pulmonary site of disease culture positive /5 44.0% Non pulmonary site of disease culturepositive 3 9/5 36.0% Includes cultures from the following anatomic sites: 8 (8.6%) bronchial fluid, (4.7%) gastric aspirate, and (.3%) upper respiratory or tracheal fluid 3 Includes cultures from the following anatomic sites: 4 (9.3%) lymph node, (4.7%) pleura, (.3%) pleural fluid, (.3%) cerebrospinal fluid and (.3%) soft tissue Note: The tuberculin skin test and IGRA were both conducted in 9 (0.9%) cases, and neither was done in 8 (8.6%) cases. Both the sputum smear and the sputum culture tests were not done in 9 (0.9%) cases. Table II-C: TB cases by x-ray results, SJC, 03 (N=43) CLINICAL FACTOR DENOMINATOR Chest X Ray Performed 4 95.3% Chest X Ray Normal 4/4 9.8% Chest X Ray Abnormal 37/4 90.% Cavitary 9/37 4.3% Non cavitary 8/37 75.7% SJCPHS Epidemiology Program 4

San Joaquin County (SJC) in 03, (N=43) County Rate = 6. Cases per 00,000 Population III. Associated Risk Factors at the Time of Diagnosis Table III-A: TB cases by select risk factors, SJC, 03 (N=43) RISK FACTOR NUMBER OF CASES Homelessness 4.7% Imprisonment.3% Long term Care Institutionalization 0 0.0% Injection Drug Use within Past Year.3% Non injection Drug Use within Past Year 4.7% Excess Alcohol Use within Past Year 9 0.9% AIDS Diagnosis.3% Diabetes Mellitus Diagnosis 8 4.9% IV. Anti Tuberculosis Drug Susceptibility Profile Table IV-A: Drug susceptibility results (N=43) MEDICATION DENOMINATOR First Line Drugs Tests Performed 38 88.4% Sensitive to all first line drugs 3/38 84.% Resistant to at least one first line drug 6/38 5.8% Isoniazid (INH) Resistant 4/38 0.5% Rifampin (RIF) Resistant /38.6% Pyrazinamide (PZA) Resistant 3/38 7.9% Ethambutol (EMB) Resistant /38.6% Multi Drug Resistant (MDR) 0/38 0.0% Extensively Drug Resistant (XDR) 3 /38.6% Susceptibility testing was performed for 8 cases with positive sputum culture only, 4 with positive culture of other body tissue or fluid only, and 6 cases with both positive sputum culture and positive culture of other body tissue or fluid. Testing was not performed for 3 clinical cases, provider diagnosed case and rapid detection (pyrosequencing) positive case without culture confirmation. MDR is defined as resistance to at least INH and RIF; count excludes XDR cases 3 XDR is defined as resistance to at least INH, RIF, one fluoroquinolone, and one of three second line injectables (i.e., amikacin, capreomycin, kanamycin) SJCPHS Epidemiology Program 5